Abstract
The endothelial lining of blood vessels is the one-cell-thick innermost layer and comprises endothelial cells. The endothelium plays an important role in the dynamic regulation of blood pressure (BP) (Fig. 9-1). Through hormones, cytokines, and other vasoactive factors, the endothelium communicates to and regulates the function of vascular smooth muscle tone. This is critical to the dynamic equilibrium of basal BP, and our understanding of how the body rapidly adjusts to changes in position or blood volume. Abnormalities of the endothelium are reflected in altered basal control of BP, and clearly contribute to the development of hypertension. In this chapter, I explore the important endothelial participants in BP control and suggest ways to modify these factors to yield normotension.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Yanagisawa M, Kurihara H, Kimura S, et al. (1988) A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 332: 411–415.
Haynes WG, Webb DJ (1994) Contribution of endogenous generation of endothelin-1 to basal vascular tone. Lancet 344: 852–854.
Krum H, Viskoper RJ, Lacourciere Y, Budde M, Charlon V (1998) The effect of an endothelin-receptor antagonist, bosentan, on blood pressure in patients with essential hypertension. Bosentan Hypertension Investigators. N Engl J Med, 338 (12): 784–790.
Giaid A, Yanagisawa M, Langleben D, Michel RP, Levy R, Shennib H, Kimura S, Masaki T, Duguid WP, Stewart DJ (1993) Expression of endothelin-1 in the lungs of patients with primary pulmonary hypertension. New Engl J Med 328: 1732–1739.
Lanese DM, Conger JD (1993) Effects of endothelin receptor antagonist on cyclosporine-induced vasoconstriction in isolated rat renal arterioles. J Clin Invest 93: 2144–2149.
Fogo A, Hellings SE, Inagami T, Kon V (1992) Endothelin receptor antagonism is protective in in vivo acute cyclosporine toxicity. Kidney Int 42: 770–774.
Corvol P, Soubrier F, Jeunemaitre X (1997) Molecular genetics of the reninangiotensin-aldosterone system in human hypertension. Pathologie Biologie 45 (3): 229–239.
Bravo EL, Gifford RW Jr (1993) Pheochromocytoma. Endocrinol Metab Clin North Am 22 (2): 329–341.
John SWM, Veress AT, Honrath U, et al. (1996) Blood pressure and fluid-electrolyte balance in mice with reduced or absent atrial natriuretic peptide. Am J Physiol 271: R109–R114.
Kishimoto I, Dubois SK, Garbers DL (1996) The heart communicates with the kidney exclusively through the guanylyl cyclase-A receptor: acute handling of sodium and water in response to volume expansion. Proc Natl Acad Sci USA 93: 6215–6219.
Hunt PJ, Espiner EA, Nichols MG, Richards AM, Yandle TG (1996) Differing biological effects of equimolar atrial and brain natriuretic peptide infusions in normal man. J Clin Endocrinol Metab 81: 3871–3876.
Burnett JC Jr, Kao PC, Hu DC, et al. (1986) Atrial natriuretic peptide elevation in congestive heart failure in the human. Science 231: 1145–1147.
Ignarro LJ (1993) Nitric oxide-mediated vasorelaxation. Thromb Haemost 70 (1): 148–151.
Maccario M, Oleandri SE, Procopio M, Grottoli S, Avogadri E, Camanni F, Ghigo E (1997) Comparison among the effects of arginine, a nitric oxide precursor, isosorbide dinitrate and molsidomine, two nitric oxide donors, on hormonal secretions and blood pressure in man. J Endocrinol Invest 20 (8): 488–492.
Baron AD (1996) Insulin and the vasculature—old actors, new roles. J Invest Med 44 (8): 406–412.
Pieper GM (1998) Review of alterations in endothelial nitric oxide production in diabetes: protective role of arginine on endothelial dysfunction. Hypertension 31 (5): 1047–1060.
Penno G, Chaturvedi N, Talmud PJ, Cotroneo P, Manto A, Nannipieri M, Luong LA, Fuller JH (1998) Effect of angiotensin-converting enzyme (ACE) gene polymorphism on progression of renal disease and the influence of ACE inhibition in IDDM patients: findings from the EUCLID Randomized Controlled Trial. EURODIAB Controlled Trial of Lisinopril in IDDM. Diabetes 47 (9): 1507–1511.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2001 Springer Science+Business Media New York
About this chapter
Cite this chapter
Levin, E.R. (2001). Role of Endothelium in Hypertension. In: Weber, M.A. (eds) Hypertension Medicine. Current Clinical Practice. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-59259-008-7_9
Download citation
DOI: https://doi.org/10.1007/978-1-59259-008-7_9
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-4757-5446-9
Online ISBN: 978-1-59259-008-7
eBook Packages: Springer Book Archive